Karen Noblett - Mar 18, 2022 Form 4 Insider Report for Axonics, Inc. (AXNX)

Role
Chief Medical Officer
Signature
/s/ Dan Dearen, as Attorney-in-Fact for Karen Noblett
Stock symbol
AXNX
Transactions as of
Mar 18, 2022
Transactions value $
-$774,359
Form type
4
Date filed
3/22/2022, 08:52 PM
Previous filing
Feb 3, 2022
Next filing
Sep 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Sale -$774K -13.5K -24.34% $57.23 42.1K Mar 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $56.93 to $57.435. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.